Tratamiento en mujeres sin deseo genésico 113 the efficacy of spironolactone versus flutamide in the treatment of hirsutism. Fertil Steril. 1994;61(4):613-6. 50 Venturoli S, Paradisi R, Bagnoli A, Colombo FM, Ravaioli B, Vianello F, et al. Low-dose flutamide (125 mg/day) as maintenance therapy in the treatment of hirsutism. Horm Res. 2001;56:25-31. 51 Muderris II, Bayram F. Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism. J Endocrinol Invest. 1999; 22:165-8. 52 Dodin S, Faure N, Cedrin I, Mechain C, Turcot-Lemay L, Guy J, et al. Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism. Clin Endocrinol (Oxf). 1995;43:575-82. 53 Kelestimur F, Sahin Y. Comparison of Diane 35 and Diane 35 plus spironolactone in the treatment of hirsutism. Fertil Steril. 1998;69:66-9. 54 Kelestimur F. Diane 35 and spironolactone combination in the treatment of hirsutism. Clin Endocrinol (Oxf). 2001 May;54:699-700. 55 Tartagni M, Schonauer LM, De Salvia MA, Cicinelli E, De Pergola G, D’Addario V. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Fertil Steril. 2000;73(4):718-23. 56 Sahin Y, Dilber S, Kelestimur F. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Fertil Steril. 2001;75:496-500. 57 Taner C, Inal M, Basogul A. Comparison of the clinical efficacy and safety of flutasmide versus flutamide plus an oral contraceptive in the treatment of hirsutism. Gynecologic and Obstetrics Investigation. 2002;54:105-8. 58 Unluhizarci KK, Everest H, Bayram F, Kelestimur F. Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism. Fertil Steril. 2002;78:1331-3. 59 Azziz R, Ehrmann D, Legro RS, Whitcomb RW, Hanley R, Fereshetian AG, et al. PCOS/Troglitazone Study Group Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial. J Clin Endocrinol Metab. 2001;186:1626-32. 60 Kelly CJ, Gordon D. The effect of metformin on hirsutism in polycystic ovary syndrome. Eur J Endocrinol. 2002; 147(2):217-21. 61 Carr BR, Breslau NA, Givens C, Byrd W, Barnett-Hamm C, Marshburn PB. Oral contraceptive pills, gonadotropinreleasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study. J Clin Endocrinol Metab. 1995;80:1169-78. 62 Azziz R, Ochoa TM, Bradley EL Jr, Potter HD, Boots LR. Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study. J Clin Endocrinol Metab. 1995;80(12):3406-11. 63 Heiner JS, Greendale GA, Kawakami AK, Lapolt PS, Fisher M, Young D, et al. Comparison of a gonadotropin-releasing hormone agonist and a low dose oral contraceptive given alone or together in the treatment of hirsutism. J Clin Endocrinol Metab. 1995;80:3412-8. 64 Carmina E, Janni A, Lobo RA. Physiological estrogen replacement may enhance the effectiveness of the gonadotropinreleasing hormone agonist in the treatment of hirsutism. J Clin Endocrinol Metab. 1994;78:126-30. 65 Liew SH. Unwanted body hair and its removal: a review. Dermatol Surg. 1999; 25:431-9. 66 Wagner RF. Physical methods for the management of hirsutism. Cutis. 1990; 45:199-202. 67 Barman Balfour JA, McCellan K. Topical eflornithine. Am J Clin Dermatol. 2001; 2:197-201. 68 Coyne PE Jr. The eflornithine story. J Am Acad Dermatol. 2001;45:784-6. 69 Richards RN, Meharg GA. Electrolysis: observations from 13 years and 140,000
114 Síndrome <strong>del</strong> <strong>Ovario</strong> Poliquístico hours of experience. J Am Acad Dermatol. 1995;33:662-6. 70 Lask G, Elman M, Slatkine M, Waldman A, Rozenberg Z. Laser-assisted hair removal by selective photothermolysis. Dermatol Surg. 1997;23:737-9. 71 Altshuler GB, Zenzie HH, Erofeev AV, Smirnov MZ, Anderson RR, Dierickx C. Contact cooling of the skin. Phys Med Biol. 1999;44:1003-23. 72 Goldberg DJ. Laser cooling. J Cutan Laser Ther. 2001;3:28-9.
Change language